{"cik":"0001649989","ticker":"OTLK","name":"Outlook Therapeutics, Inc.","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"Nasdaq","state_of_incorporation":"DE","fiscal_year_end":"0930","first_filing_date":"2026-05-13","last_filing_date":"2026-07-24","url":"/sec/cik-0001649989","insider_summary":{"total_transactions":20,"unique_insiders":6,"latest_transaction":"2026-08-12"},"recent_filings":[{"accession_number":"0001104659-26-112356","form_type":"8-K","form_type_family":"current","doc_date":"2026-09-30","title":"8-K — Outlook Therapeutics, Inc. — 2026-09-30","url_slug":"/sec/cik-0001649989/8-k/0001104659-26-112356","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-112356-index.html"},{"accession_number":"0001104659-26-108952","form_type":"8-K","form_type_family":"current","doc_date":"2026-09-18","title":"8-K — Outlook Therapeutics, Inc. — 2026-09-18","url_slug":"/sec/cik-0001649989/8-k/0001104659-26-108952","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-108952-index.html"},{"accession_number":"0002074701-26-000005","form_type":"4","form_type_family":"insider","doc_date":"2026-09-02","title":"4 — Outlook Therapeutics, Inc. — 2026-09-02","url_slug":"/sec/cik-0001649989/4/0002074701-26-000005","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0002074701-26-000005-index.html"},{"accession_number":"0002074701-26-000003","form_type":"3","form_type_family":"insider","doc_date":"2026-09-02","title":"3 — Outlook Therapeutics, Inc. — 2026-09-02","url_slug":"/sec/cik-0001649989/3/0002074701-26-000003","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0002074701-26-000003-index.html"},{"accession_number":"0001104659-26-102446","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-27","title":"8-K — Outlook Therapeutics, Inc. — 2026-08-27","url_slug":"/sec/cik-0001649989/8-k/0001104659-26-102446","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-102446-index.html"},{"accession_number":"0001104659-26-098415","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-08-18","title":"10-Q — Outlook Therapeutics, Inc. — 2026-08-18","url_slug":"/sec/cik-0001649989/10-q/0001104659-26-098415","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-098415-index.html"},{"accession_number":"0001104659-26-097838","form_type":"NT 10-Q","form_type_family":"other","doc_date":"2026-08-17","title":"NT 10-Q — Outlook Therapeutics, Inc. — 2026-08-17","url_slug":"/sec/cik-0001649989/nt-10-q/0001104659-26-097838","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-097838-index.html"},{"accession_number":"0000899140-26-000895","form_type":"SCHEDULE 13D/A","form_type_family":"other","doc_date":"2026-08-14","title":"SCHEDULE 13D/A — Outlook Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001649989/schedule-13d-a/0000899140-26-000895","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0000899140-26-000895-index.html"},{"accession_number":"0001104659-26-096510","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-14","title":"8-K — Outlook Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001649989/8-k/0001104659-26-096510","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-096510-index.html"},{"accession_number":"0001104659-26-096478","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-14","title":"8-K — Outlook Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001649989/8-k/0001104659-26-096478","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-096478-index.html"},{"accession_number":"0001104659-26-097406","form_type":"4","form_type_family":"insider","doc_date":"2026-08-14","title":"4 — Outlook Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001649989/4/0001104659-26-097406","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-097406-index.html"},{"accession_number":"0000899140-26-000894","form_type":"4","form_type_family":"insider","doc_date":"2026-08-14","title":"4 — Outlook Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001649989/4/0000899140-26-000894","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0000899140-26-000894-index.html"},{"accession_number":"0001104659-26-096504","form_type":"424B5","form_type_family":"registration","doc_date":"2026-08-14","title":"424B5 — Outlook Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001649989/424b5/0001104659-26-096504","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-096504-index.html"},{"accession_number":"0001104659-26-094848","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-12","title":"8-K — Outlook Therapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001649989/8-k/0001104659-26-094848","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-094848-index.html"},{"accession_number":"0001104659-26-094970","form_type":"424B5","form_type_family":"registration","doc_date":"2026-08-12","title":"424B5 — Outlook Therapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001649989/424b5/0001104659-26-094970","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-094970-index.html"},{"accession_number":"0001649989-26-000008","form_type":"4","form_type_family":"insider","doc_date":"2026-07-29","title":"4 — Outlook Therapeutics, Inc. — 2026-07-29","url_slug":"/sec/cik-0001649989/4/0001649989-26-000008","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001649989-26-000008-index.html"},{"accession_number":"0001104659-26-086685","form_type":"8-K","form_type_family":"current","doc_date":"2026-07-24","title":"8-K — Outlook Therapeutics, Inc. — 2026-07-24","url_slug":"/sec/cik-0001649989/8-k/0001104659-26-086685","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-086685-index.html"},{"accession_number":"0001104659-26-086406","form_type":"8-K","form_type_family":"current","doc_date":"2026-07-24","title":"8-K — Outlook Therapeutics, Inc. — 2026-07-24","url_slug":"/sec/cik-0001649989/8-k/0001104659-26-086406","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-086406-index.html"},{"accession_number":"0001649989-26-000006","form_type":"4","form_type_family":"insider","doc_date":"2026-07-23","title":"4 — Outlook Therapeutics, Inc. — 2026-07-23","url_slug":"/sec/cik-0001649989/4/0001649989-26-000006","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001649989-26-000006-index.html"},{"accession_number":"9999999995-26-002376","form_type":"EFFECT","form_type_family":"other","doc_date":"2026-07-21","title":"EFFECT — Outlook Therapeutics, Inc. — 2026-07-21","url_slug":"/sec/cik-0001649989/effect/9999999995-26-002376","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/9999999995-26-002376-index.html"},{"accession_number":"0001104659-26-085430","form_type":"424B3","form_type_family":"registration","doc_date":"2026-07-21","title":"424B3 — Outlook Therapeutics, Inc. — 2026-07-21","url_slug":"/sec/cik-0001649989/424b3/0001104659-26-085430","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-085430-index.html"},{"accession_number":"0001104659-26-084621","form_type":"S-3","form_type_family":"registration","doc_date":"2026-07-17","title":"S-3 — Outlook Therapeutics, Inc. — 2026-07-17","url_slug":"/sec/cik-0001649989/s-3/0001104659-26-084621","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-084621-index.html"},{"accession_number":"0001104659-26-084242","form_type":"8-K","form_type_family":"current","doc_date":"2026-07-16","title":"8-K — Outlook Therapeutics, Inc. — 2026-07-16","url_slug":"/sec/cik-0001649989/8-k/0001104659-26-084242","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-084242-index.html"},{"accession_number":"0001104659-26-082361","form_type":"DEFA14A","form_type_family":"proxy","doc_date":"2026-07-10","title":"DEFA14A — Outlook Therapeutics, Inc. — 2026-07-10","url_slug":"/sec/cik-0001649989/defa14a/0001104659-26-082361","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-082361-index.html"},{"accession_number":"0001104659-26-081849","form_type":"DRS","form_type_family":"other","doc_date":"2026-07-08","title":"DRS — Outlook Therapeutics, Inc. — 2026-07-08","url_slug":"/sec/cik-0001649989/drs/0001104659-26-081849","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649989/0001104659-26-081849-index.html"}],"related_endpoints":{"profile":"/sec/OTLK/profile","timeline":"/sec/OTLK/timeline","peers":"/sec/OTLK/peers","insider_pulse":"/sec/OTLK/insider-pulse","insider_summary":"/sec/OTLK/insider-summary","insider_transactions":"/sec/OTLK/insider-transactions","form144":"/sec/OTLK/form144","holdings_as_filer":"/sec/OTLK/holdings","financial_facts":"/sec/OTLK/financial-facts","derivatives":"/sec/OTLK/derivatives","officers":"/sec/OTLK/officers","insider_network":"/sec/OTLK/insider-network","risk_flags":"/sec/OTLK/risk-flags","filings":"/sec/OTLK/filings","cross_topic_dossier":"/api/v1/dossier?ticker=OTLK"}}